ImpriMed is a biotech startup that innovates the method of cancer care based on science and medicine. Our goal is to help oncologists provide more tailored treatment approaches; based on data-driven artificial intelligence from ex vivo cellular data. ImpriMed is a fast-growing, dynamic team of experts who will not rest until their mission is accomplished, which is to provide precision medicine for pet cancer care to all.